Vaxart, Inc. (VXRT)
NASDAQ: VXRT · IEX Real-Time Price · USD
0.815
+0.001 (0.14%)
At close: May 31, 2024, 4:00 PM
0.850
+0.035 (4.28%)
After-hours: May 31, 2024, 7:46 PM EDT

Vaxart Revenue

Vaxart had revenue of $8.89M in the twelve months ending March 31, 2024, with 1,174.75% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $2.18M with 223.11% year-over-year growth. In the year 2023, Vaxart had annual revenue of $7.38M with 6,796.26% growth.

Revenue (ttm)
$8.89M
Revenue Growth
+1,174.75%
P/S Ratio
16.22
Revenue / Employee
$81,514
Employees
109
Market Cap
144.12M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20237.38M7.27M6,796.26%
Dec 31, 2022107.00K-785.00K-88.00%
Dec 31, 2021892.00K-3.15M-77.95%
Dec 31, 20204.05M-5.82M-58.97%
Dec 31, 20199.86M5.70M137.12%
Dec 31, 20184.16M-1.68M-28.77%
Dec 31, 20175.84M-3.46M-37.22%
Jun 30, 20169.30M-15.30M-62.20%
Jun 30, 201524.60M-44.10M-64.19%
Jun 30, 201468.70M35.10M104.46%
Jun 30, 201333.60M13.20M64.71%
Jun 30, 201220.40M7.90M63.20%
Jun 25, 201112.50M-22.51M-64.29%
Dec 25, 201035.01M24.52M233.73%
Dec 26, 200910.49M--
Dec 27, 20080--
Dec 29, 20070--
Dec 30, 20060--
Dec 31, 20050--
Dec 25, 2004142.18M-34.39M-19.48%
Dec 27, 2003176.57M-19.40M-9.90%
Dec 28, 2002195.97M-38.86M-16.55%
Dec 29, 2001234.83M6.05M2.64%
Dec 30, 2000228.78M-4.82M-2.06%
Dec 31, 1999233.60M-9.48M-3.90%
Dec 31, 1998243.09M14.34M6.27%
Dec 31, 1997228.74M-11.17M-4.65%
Dec 31, 1996239.91M43.98M22.45%
Dec 31, 1995195.93M31.50M19.16%
Dec 31, 1994164.43M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Quipt Home Medical 185.39M
Seres Therapeutics 126.85M
TELA Bio 63.15M
CVRx, Inc. 42.09M
ClearPoint Neuro 26.16M
ProQR Therapeutics 14.66M
Veru Inc. 13.48M
Cardiff Oncology 610.00K
Revenue Rankings